China Pharma Holdings, Inc.CPHINYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank79
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-8.59
↑ 91% vs avg
Percentile
P79
Within normal range
Streak
4 yr
Consecutive growthElevated
Average
-97.05
Historical baseline
PeriodValueYoY Change
2024-8.59+58.8%
2023-20.83+67.2%
2022-63.51+80.6%
2021-327.43+8.7%
2020-358.67-1259.5%
2019-26.38+52.2%
2018-55.23-162.9%
2017-21.01+67.8%
2016-65.31-177.8%
2015-23.51-